2024 annual financial data
Solid Biosciences 2024 Operating margin
Solid Biosciences 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -129,728,000 USD and net income was -124,697,000 USD.
Operating cash flow was -100,012,000 USD.
Get free Solid Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -129,728,000 USD
- Net income
- -124,697,000 USD
- Operating cash flow
- -100,012,000 USD